TransCelerate BioPharma

TransCelerate BioPharma’s Clinical Trial Comparator Network now active

Wednesday, August 7, 2013 11:26 AM

TransCelerate BioPharma has reached its primary milestone in its Clinical Trial Comparator Network initiative. Formed to establish reliable, rapid sourcing of quality drug products for use in clinical trials, the Comparator Network will enable accelerated clinical trial timelines and enhanced patient safety.

More... »

Accenture launches Accelerated R&D Services

Friday, July 12, 2013 02:05 PM

Accenture, a global management consulting, technology services and outsourcing company, has launched the Accenture Accelerated R&D Services, a business service focused on delivering streamlined and integrated R&D functions to help pharmaceutical companies bring new medications to patients using a more collaborative approach. Accenture is investing more than $200 million to deliver this fully-integrated, technology-enabled global business service.

More... »

TransCelerate initiates common criteria for investigator and site qualification and training

Friday, June 21, 2013 01:15 PM

TransCelerate BioPharma, a nonprofit focused on advancing innovation in R&D, has reached several milestones in its initiative to realize efficiencies across clinical trial investigator and site qualification and training ("SQT") efforts.

More... »

TransCelerate reveals collaborative methodology for risk-based monitoring

Monday, June 3, 2013 11:25 AM

TransCelerate BioPharma, an independent nonprofit focused on accelerating the development of new medicines, has released a position paper outlining a methodology for risk-based site monitoring (RBM) that could modernize and streamline the way studies are conducted and monitored.  The RBM position paper reflects TransCelerate's collaborative approach to improve speed, efficiency and capabilities in bringing new therapeutics to patients. 

More... »

Janssen R&D establishes global cross-pharma clinical trial Investigator Databank

Monday, November 19, 2012 10:18 AM

Janssen Research & Development, based in Raritan, N.J., has established a global cross-pharmaceutical Investigator Databank designed to improve efficiencies of industry-sponsored clinical trials. Merck and Eli Lilly are the first two companies to join Janssen in this effort.

More... »

10 pharmas form nonprofit TransCelerate to accelerate R&D of new medicines

Wednesday, September 19, 2012 02:46 PM

Ten biopharmaceutical companies have formed a non-profit organization, TransCelerate BioPharma, to accelerate the development of new medicines. Participants include Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi.

More... »